The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease
A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose t...
Gespeichert in:
Veröffentlicht in: | The European journal of neuroscience 2012-09, Vol.36 (6), p.2822-2829 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2829 |
---|---|
container_issue | 6 |
container_start_page | 2822 |
container_title | The European journal of neuroscience |
container_volume | 36 |
creator | Sourani, Daphna Eitan, Renana Gordon, Noam Goelman, Gadi |
description | A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease.
A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. |
doi_str_mv | 10.1111/j.1460-9568.2012.08200.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1093447848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1041143449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvpX0C-wSXBn7GDxAFVpQWtCq1WasXFchwv9ZLEaSYRu_8ep7vsub7YM37emcODEKYkp-l83ORUFCQrZaFzRijLiWaE5NsXaHH8eIkWpJQ807S4P0FvADaEEF0I-RqdMKaUKAVboHH14PGDrXw3NRa7OPWNBzymZh1724bOD7-Dw7arn5rghzjGQxN2MPoWPmHb901wdgyxw2PEte8HDzBXocM_7fAndBC794DrAN6Cf4terW0D_uxwn6LV14vV-VW2_HH57fzLMnOiJCSTzBfSKabpmlJXUFtpxXlFla9FxepUKeec0sWaUFopZyVxWnBSVIRKyfkp-rAf2w_xcfIwmjaA801jOx8nMJSUXAilhX4GKigViS4TqveoGyLA4NemH0Jrh12CzGzHbMwswcwSzGzHPNkx2xR9d9gyVa2vj8H_OhLweQ_8DY3fPXuwufh-Pb9SPtvnQzKzPeaTAVMorqS5u740N_LXkt3yK3PD_wFCIq3O</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1041143449</pqid></control><display><type>article</type><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</creator><creatorcontrib>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</creatorcontrib><description>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease.
A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</description><identifier>ISSN: 0953-816X</identifier><identifier>EISSN: 1460-9568</identifier><identifier>DOI: 10.1111/j.1460-9568.2012.08200.x</identifier><identifier>PMID: 22774942</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>6-Hydroxydopamine ; 6-hydroxydopamine rat model ; Animal models ; Animals ; Antiparkinson Agents - pharmacology ; Apomorphine - pharmacology ; Basal ganglia ; Dentate gyrus ; Depression ; Depression - etiology ; Dopamine ; Dopamine - physiology ; Etiology ; Habenula ; Habenula - physiopathology ; Hippocampus ; Hippocampus - physiopathology ; lateral habenula ; Magnetic Resonance Imaging ; Male ; manganese-enhanced magnetic resonance imaging ; Movement disorders ; Neural networks ; Neurodegenerative diseases ; Neuropsychological Tests ; Novelty ; Parkinson's disease ; Parkinsonian Disorders - complications ; Parkinsonian Disorders - drug therapy ; Parkinsonian Disorders - physiopathology ; raphe ; Raphe nuclei ; Raphe Nuclei - physiopathology ; Rats ; Rats, Sprague-Dawley ; Serotonin ; Serotonin - physiology ; Swimming ; Thalamus ; Thalamus - physiopathology ; Therapeutic applications</subject><ispartof>The European journal of neuroscience, 2012-09, Vol.36 (6), p.2822-2829</ispartof><rights>2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd</rights><rights>2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</citedby><cites>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1460-9568.2012.08200.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1460-9568.2012.08200.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22774942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sourani, Daphna</creatorcontrib><creatorcontrib>Eitan, Renana</creatorcontrib><creatorcontrib>Gordon, Noam</creatorcontrib><creatorcontrib>Goelman, Gadi</creatorcontrib><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><title>The European journal of neuroscience</title><addtitle>Eur J Neurosci</addtitle><description>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease.
A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</description><subject>6-Hydroxydopamine</subject><subject>6-hydroxydopamine rat model</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Apomorphine - pharmacology</subject><subject>Basal ganglia</subject><subject>Dentate gyrus</subject><subject>Depression</subject><subject>Depression - etiology</subject><subject>Dopamine</subject><subject>Dopamine - physiology</subject><subject>Etiology</subject><subject>Habenula</subject><subject>Habenula - physiopathology</subject><subject>Hippocampus</subject><subject>Hippocampus - physiopathology</subject><subject>lateral habenula</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>manganese-enhanced magnetic resonance imaging</subject><subject>Movement disorders</subject><subject>Neural networks</subject><subject>Neurodegenerative diseases</subject><subject>Neuropsychological Tests</subject><subject>Novelty</subject><subject>Parkinson's disease</subject><subject>Parkinsonian Disorders - complications</subject><subject>Parkinsonian Disorders - drug therapy</subject><subject>Parkinsonian Disorders - physiopathology</subject><subject>raphe</subject><subject>Raphe nuclei</subject><subject>Raphe Nuclei - physiopathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin</subject><subject>Serotonin - physiology</subject><subject>Swimming</subject><subject>Thalamus</subject><subject>Thalamus - physiopathology</subject><subject>Therapeutic applications</subject><issn>0953-816X</issn><issn>1460-9568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EokvpX0C-wSXBn7GDxAFVpQWtCq1WasXFchwv9ZLEaSYRu_8ep7vsub7YM37emcODEKYkp-l83ORUFCQrZaFzRijLiWaE5NsXaHH8eIkWpJQ807S4P0FvADaEEF0I-RqdMKaUKAVboHH14PGDrXw3NRa7OPWNBzymZh1724bOD7-Dw7arn5rghzjGQxN2MPoWPmHb901wdgyxw2PEte8HDzBXocM_7fAndBC794DrAN6Cf4terW0D_uxwn6LV14vV-VW2_HH57fzLMnOiJCSTzBfSKabpmlJXUFtpxXlFla9FxepUKeec0sWaUFopZyVxWnBSVIRKyfkp-rAf2w_xcfIwmjaA801jOx8nMJSUXAilhX4GKigViS4TqveoGyLA4NemH0Jrh12CzGzHbMwswcwSzGzHPNkx2xR9d9gyVa2vj8H_OhLweQ_8DY3fPXuwufh-Pb9SPtvnQzKzPeaTAVMorqS5u740N_LXkt3yK3PD_wFCIq3O</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>Sourani, Daphna</creator><creator>Eitan, Renana</creator><creator>Gordon, Noam</creator><creator>Goelman, Gadi</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>201209</creationdate><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><author>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>6-Hydroxydopamine</topic><topic>6-hydroxydopamine rat model</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Apomorphine - pharmacology</topic><topic>Basal ganglia</topic><topic>Dentate gyrus</topic><topic>Depression</topic><topic>Depression - etiology</topic><topic>Dopamine</topic><topic>Dopamine - physiology</topic><topic>Etiology</topic><topic>Habenula</topic><topic>Habenula - physiopathology</topic><topic>Hippocampus</topic><topic>Hippocampus - physiopathology</topic><topic>lateral habenula</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>manganese-enhanced magnetic resonance imaging</topic><topic>Movement disorders</topic><topic>Neural networks</topic><topic>Neurodegenerative diseases</topic><topic>Neuropsychological Tests</topic><topic>Novelty</topic><topic>Parkinson's disease</topic><topic>Parkinsonian Disorders - complications</topic><topic>Parkinsonian Disorders - drug therapy</topic><topic>Parkinsonian Disorders - physiopathology</topic><topic>raphe</topic><topic>Raphe nuclei</topic><topic>Raphe Nuclei - physiopathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin</topic><topic>Serotonin - physiology</topic><topic>Swimming</topic><topic>Thalamus</topic><topic>Thalamus - physiopathology</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sourani, Daphna</creatorcontrib><creatorcontrib>Eitan, Renana</creatorcontrib><creatorcontrib>Gordon, Noam</creatorcontrib><creatorcontrib>Goelman, Gadi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>The European journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sourani, Daphna</au><au>Eitan, Renana</au><au>Gordon, Noam</au><au>Goelman, Gadi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</atitle><jtitle>The European journal of neuroscience</jtitle><addtitle>Eur J Neurosci</addtitle><date>2012-09</date><risdate>2012</risdate><volume>36</volume><issue>6</issue><spage>2822</spage><epage>2829</epage><pages>2822-2829</pages><issn>0953-816X</issn><eissn>1460-9568</eissn><abstract>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease.
A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22774942</pmid><doi>10.1111/j.1460-9568.2012.08200.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-816X |
ispartof | The European journal of neuroscience, 2012-09, Vol.36 (6), p.2822-2829 |
issn | 0953-816X 1460-9568 |
language | eng |
recordid | cdi_proquest_miscellaneous_1093447848 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | 6-Hydroxydopamine 6-hydroxydopamine rat model Animal models Animals Antiparkinson Agents - pharmacology Apomorphine - pharmacology Basal ganglia Dentate gyrus Depression Depression - etiology Dopamine Dopamine - physiology Etiology Habenula Habenula - physiopathology Hippocampus Hippocampus - physiopathology lateral habenula Magnetic Resonance Imaging Male manganese-enhanced magnetic resonance imaging Movement disorders Neural networks Neurodegenerative diseases Neuropsychological Tests Novelty Parkinson's disease Parkinsonian Disorders - complications Parkinsonian Disorders - drug therapy Parkinsonian Disorders - physiopathology raphe Raphe nuclei Raphe Nuclei - physiopathology Rats Rats, Sprague-Dawley Serotonin Serotonin - physiology Swimming Thalamus Thalamus - physiopathology Therapeutic applications |
title | The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T23%3A49%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20habenula%20couples%20the%20dopaminergic%20and%20the%20serotonergic%20systems:%20application%20to%20depression%20in%20Parkinson's%20disease&rft.jtitle=The%20European%20journal%20of%20neuroscience&rft.au=Sourani,%20Daphna&rft.date=2012-09&rft.volume=36&rft.issue=6&rft.spage=2822&rft.epage=2829&rft.pages=2822-2829&rft.issn=0953-816X&rft.eissn=1460-9568&rft_id=info:doi/10.1111/j.1460-9568.2012.08200.x&rft_dat=%3Cproquest_cross%3E1041143449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1041143449&rft_id=info:pmid/22774942&rfr_iscdi=true |